V. Vieillard, J. Strominger, and P. Debré, NK cytotoxicity against CD4+ T cells during HIV-1 infection: A gp41 peptide induces the expression of an NKp44 ligand, Proceedings of the National Academy of Sciences, vol.387, issue.6631, pp.10981-10987, 2005.
DOI : 10.1038/387426a0

F. Baychelier, A. Sennepin, M. Ermonval, K. Dorgham, P. Debré et al., Identification of a cellular ligand for the natural killer receptor NKp44, Blood, pp.10-1182, 2013.

N. Reymond, A. Imbert, E. Devilard, S. Fabre, C. Chabannon et al., DNAM-1 and PVR Regulate Monocyte Migration through Endothelial Junctions, The Journal of Experimental Medicine, vol.163, issue.10, pp.1331-1372, 2004.
DOI : 10.1038/sj.onc.1205875
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211807

A. Bialoszewska, F. Baychelier, J. Niderla-bielinska, A. Czop, P. Debré et al., Constitutive expression of ligand for natural killer cell NKp44 receptor (NKp44L) by normal human articular chondrocytes, Cellular Immunology, vol.285, issue.1-2, pp.6-9, 2013.
DOI : 10.1016/j.cellimm.2013.08.005

A. Murray and T. Hunt, The Cell Cycle, American Zoologist, vol.29, issue.2, 1993.
DOI : 10.1093/icb/29.2.511
URL : https://hal.archives-ouvertes.fr/hal-01535297

G. Williams and K. Stoeber, The cell cycle and cancer, The Journal of Pathology, vol.61, issue.suppl 1, pp.352-64, 2012.
DOI : 10.1002/path.3022

L. Hartwell and T. Weinert, Checkpoints: controls that ensure the order of cell cycle events, Science, vol.246, issue.4930, pp.629-663, 1989.
DOI : 10.1126/science.2683079

J. Bartek, C. Lukas, and J. Lukas, Checking on DNA damage in S phase doi:10.1038/nrm1493 17. Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time CDKs and cancer: a changing paradigm, Nat Rev Mol Cell Biol Nat Rev Mol Cell Biol Malumbres M, Barbacid M. Cell cycle Nat Rev Cancer, vol.5, issue.9, pp.792-804379, 1038.
DOI : 10.1038/nrm1493

J. Siliciano, C. Canman, Y. Taya, K. Sakaguchi, E. Appella et al., DNA damage induces phosphorylation of the amino terminus of?p53, Genes & Development, vol.11, issue.24, 1997.
DOI : 10.1101/gad.11.24.3471

J. Harbour and D. Dean, The Rb/E2F pathway: expanding roles and emerging paradigms, Genes & Development, vol.14, issue.19, pp.2393-409, 2000.
DOI : 10.1101/gad.813200

E. Nolte-'t-hoen, C. Almeida, N. Cohen, S. Nedvetzki, H. Yarwood et al., Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication, Blood, vol.109, issue.2, pp.670-673, 2007.
DOI : 10.1182/blood-2006-07-036509

A. Byrd, S. Hoffmann, M. Jarahian, F. Momburg, and C. Watzl, Expression Analysis of the Ligands for the Natural Killer Cell Receptors NKp30 and NKp44, PLoS ONE, vol.176, issue.12, 2007.
DOI : 10.1371/journal.pone.0001339.t002

H. Chen, S. Tsai, and G. Leone, Emerging roles of E2Fs in cancer: an exit from cell cycle control, Nature Reviews Cancer, vol.94, issue.11, pp.785-97, 2009.
DOI : 10.1038/nrc2696

H. Jung, B. Hsiung, K. Pestal, E. Procyk, and D. Raulet, RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry, The Journal of Experimental Medicine, vol.14, issue.13, pp.2409-2431, 2012.
DOI : 10.1093/oxfordjournals.jbchem.a021242

X. Liu, S. Ho, J. Tan, N. Kamran, and S. Gasser, Ras Activation Induces Expression of Raet1 Family NK Receptor Ligands, The Journal of Immunology, vol.189, issue.4, pp.1826-1860, 2012.
DOI : 10.4049/jimmunol.1200965

A. El-gazzar, V. Groh, and T. Spies, Immunobiology and Conflicting Roles of the Human NKG2D Lymphocyte Receptor and Its Ligands in Cancer, The Journal of Immunology, vol.191, issue.4, pp.1509-1524, 2013.
DOI : 10.4049/jimmunol.1301071

S. Gasser, S. Orsulic, E. Brown, and D. Raulet, The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor, Nature, vol.19, issue.7054, pp.1186-90, 2005.
DOI : 10.1038/nature03884

C. Cerboni, A. Zingoni, M. Cippitelli, M. Piccoli, L. Frati et al., Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis, Blood, vol.110, issue.2, pp.606-621, 2006.
DOI : 10.1182/blood-2006-10-052720

D. Raulet and N. Guerra, Oncogenic stress sensed by the immune system: role of natural killer cell receptors, Nature Reviews Immunology, vol.105, issue.8, pp.568-80, 2009.
DOI : 10.1038/nri2604

S. Gasser and D. Raulet, Activation and self-tolerance of natural killer cells, Immunological Reviews, vol.158, issue.1, pp.130-172, 2006.
DOI : 10.1111/j.0300-9475.2004.01363.x

S. Madar, I. Goldstein, and V. Rotter, Did Experimental Biology Die? Lessons from 30 Years of p53 Research, Cancer Research, vol.69, issue.16, pp.6378-80, 2009.
DOI : 10.1158/0008-5472.CAN-09-0940

S. Textor, N. Fiegler, A. Arnold, A. Porgador, T. Hofmann et al., Human NK Cells Are Alerted to Induction of p53 in Cancer Cells by Upregulation of the NKG2D Ligands ULBP1 and ULBP2, Cancer Research, vol.71, issue.18, pp.5998-6009, 2011.
DOI : 10.1158/0008-5472.CAN-10-3211

N. Issaeva, P. Bozko, M. Enge, M. Protopopova, L. Verhoef et al., Small molecule RITA binds to p53, blocks p53???HDM-2 interaction and activates p53 function in tumors, Nature Medicine, vol.19, issue.12, pp.1321-810, 1038.
DOI : 10.1073/pnas.031470698

L. Vassilev, B. Vu, B. Graves, D. Carvajal, F. Podlaski et al., In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2, Science, vol.303, issue.5659, pp.844-852, 2004.
DOI : 10.1126/science.1092472

N. Fiegler, S. Textor, A. Arnold, A. Rölle, I. Oehme et al., Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells, Blood, vol.122, issue.5, pp.684-93, 2013.
DOI : 10.1182/blood-2013-02-482513

A. Sinclair, S. Yarranton, and C. Schelcher, DNA-damage response pathways triggered by viral replication, Expert Reviews in Molecular Medicine, vol.8, issue.05, pp.1-11, 2006.
DOI : 10.1017/S1462399406010544
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221734

A. Fauci, D. Mavilio, and S. Kottilil, NK cells in HIV infection: Paradigm for protection or targets for ambush, Nature Reviews Immunology, vol.99, issue.11, pp.835-878, 2005.
DOI : 10.1084/jem.190.6.793

S. Jost and M. Altfeld, Evasion from NK cell-mediated immune responses by HIV-1, Microbes and Infection, vol.14, issue.11, pp.904-919, 2012.
DOI : 10.1016/j.micinf.2012.05.001

M. Roshal, B. Kim, Y. Zhu, P. Nghiem, and V. Planelles, Activation of the ATR-mediated DNA Damage Response by the HIV-1 Viral Protein R, Journal of Biological Chemistry, vol.278, issue.28, pp.25879-86, 2003.
DOI : 10.1074/jbc.M303948200

W. Goh, M. Rogel, C. Kinsey, S. Michael, P. Fultz et al., HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo, Nature Medicine, vol.268, issue.1, pp.65-7110, 1038.
DOI : 10.1074/jbc.272.14.9166

L. Rouzic, E. Belaidouni, N. Estrabaud, E. Morel, M. Rain et al., HIV1 Vpr Arrests the Cell Cycle by Recruiting DCAF1/VprBP, a Receptor of the Cul4-DDB1 Ubiquitin Ligase, Cell Cycle, vol.6, issue.2, pp.182-190, 2007.
DOI : 10.4161/cc.6.2.3732

J. Ward, Z. Davis, J. Dehart, E. Zimmerman, A. Bosque et al., HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATRmediated DNA damage response, PLoS Pathog, 2009.

A. Lopez-soto, A. Quinones-lombrana, R. Lopez-arbesu, C. Lopez-larrea, and S. Gonzalez, Transcriptional Regulation of ULBP1, a Human Ligand of the NKG2D Receptor, Journal of Biological Chemistry, vol.281, issue.41, pp.30419-30449, 2006.
DOI : 10.1074/jbc.M604868200

T. Ndolo, N. Dhillon, H. Nguyen, G. M. Mudryj, M. Dandekar et al., Simian Immunodeficiency Virus Nef Protein Delays the Progression of CD4+ T Cells through G1/S Phase of the Cell Cycle, Journal of Virology, vol.76, issue.8, pp.3587-95, 2002.
DOI : 10.1128/JVI.76.8.3587-3595.2002

H. Fausther-bovendo, N. Sol-foulon, D. Candotti, H. Agut, O. Schwartz et al., HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells, Madrid AS, Ganem D. Kaposi's sarcoma, pp.1077-87, 2009.
DOI : 10.1097/QAD.0b013e32832cb26b
URL : https://hal.archives-ouvertes.fr/pasteur-00458079

A. Zingoni, T. Sornasse, B. Cocks, Y. Tanaka, A. Santoni et al., Cross-Talk between Activated Human NK Cells and CD4+ T Cells via OX40-OX40 Ligand Interactions, The Journal of Immunology, vol.173, issue.6, pp.3716-3740, 2004.
DOI : 10.4049/jimmunol.173.6.3716

M. Barber, T. Zhang, B. Gagne, and C. Sentman, NK Cells Negatively Regulate Antigen Presentation and Tumor-Specific CTLs in a Syngeneic Lymphoma Model, The Journal of Immunology, vol.178, issue.10, pp.6140-6147, 2007.
DOI : 10.4049/jimmunol.178.10.6140

A. Zingoni, M. Ardolino, A. Santoni, and C. Cerboni, NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses, Frontiers in Immunology, vol.3, 2012.
DOI : 10.3389/fimmu.2012.00408
URL : https://hal.archives-ouvertes.fr/pasteur-00966878

M. Ardolino, A. Zingoni, C. Cerboni, F. Cecere, A. Soriani et al., DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction, Blood, vol.117, issue.18
DOI : 10.1182/blood-2010-08-300954